Thalidomide and Coronary artery stenosis - a phase IV clinical study of FDA data

Summary:

Coronary artery stenosis is reported as a side effect among people who take Thalidomide (thalidomide), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Gabapentin, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Coronary artery stenosis when taking Thalidomide. It is created by eHealthMe based on reports of 16,470 people who have side effects when taking Thalidomide from the FDA, and is updated regularly.

What is Thalidomide?

Thalidomide has active ingredients of thalidomide. eHealthMe is studying from 16,473 Thalidomide users. Check the latest studies of Thalidomide.

What is Coronary artery stenosis?

Coronary artery stenosis (narrowing of coronary artery) is found to be associated with 606 drugs and 829 conditions by eHealthMe. Check the latest studies of Coronary artery stenosis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 02, 2026

16,470 people reported to have side effects when taking Thalidomide.
Among them, 15 people (0.09%) have Coronary artery stenosis.

Could Thalidomide cause Coronary artery stenosis?

Among these 15 people:

How long have people been on Thalidomide when they have Coronary artery stenosis? *

  • < 1 month: 0.0 %
  • 1 - 6 months: 75.0 %
  • 6 - 12 months: 12.5 %
  • 1 - 2 years: 12.5 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Coronary artery stenosis when taking Thalidomide? *

  • female: 7.69 %
  • male: 92.31 %

What is the age of people who have Coronary artery stenosis when taking Thalidomide? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 8.33 %
  • 50-59: 33.33 %
  • 60+: 58.33 %

What are other drugs people take besides Thalidomide? *

  1. Neurontin: 4 people, 26.67%
  2. Zometa: 4 people, 26.67%
  3. Aredia: 4 people, 26.67%
  4. Gabapentin: 4 people, 26.67%
  5. Darzalex: 3 people, 20.00%
  6. Decadron: 3 people, 20.00%
  7. Heparin: 3 people, 20.00%
  8. Ondansetron: 3 people, 20.00%
  9. Melphalan: 3 people, 20.00%
  10. Furosemide: 3 people, 20.00%

What are other side effects people have besides Coronary artery stenosis? *

  1. Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 5 people, 33.33%
  2. Atherosclerosis (disorder of the arteries): 5 people, 33.33%
  3. Constipation: 5 people, 33.33%
  4. Cough: 4 people, 26.67%
  5. Osteomyelitis (infection of bone): 4 people, 26.67%
  6. Nausea And Vomiting: 4 people, 26.67%
  7. Cardiac Failure: 4 people, 26.67%
  8. Cardiac Failure Congestive: 4 people, 26.67%
  9. Chest Pain: 4 people, 26.67%
  10. Emotional Distress: 4 people, 26.67%

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 8 people, 53.33%
  2. Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 2 people, 13.33%
  3. Anaemia (lack of blood): 2 people, 13.33%
  4. Amyotrophic Lateral Sclerosis (nervous system disease that attacks nerve cells called neurons in your brain and spinal cord): 2 people, 13.33%
  5. Pyogenic Liver Abscess (liver abscess caused by bacteria): 1 person, 6.67%
  6. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 6.67%
  7. Metastases To Bone (cancer spreads to bone): 1 person, 6.67%
  8. Lupus Nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue): 1 person, 6.67%
  9. Chronic Myelomonocytic Leukaemia (cancers of the blood-forming cells of the bone marrow): 1 person, 6.67%
  10. Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Thalidomide and have Coronary artery stenosis?

- Check whether Coronary artery stenosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Thalidomide:

Coronary artery stenosis treatments and more:

How severe was Coronary artery stenosis and when was it recovered:

Expand to all the drugs that have ingredients of thalidomide:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Thalidomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Coronary artery stenosis:

Browse all the conditions that are associated with Coronary artery stenosis:


How the study uses the data?

The study uses data from the FDA. It is based on thalidomide (the active ingredients of Thalidomide) and Thalidomide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: